Oracle’s $638 Billion Backlog Masks a Cash-Flow Crisis That Has the Stock Near a 52-Week Low

Oracle faces a stark contrast between massive AI-driven demand and financial strain, with $750B in OpenAI commitments, a $638B backlog, but $156B debt and negative free cash flow.

Oracle is living a double life. The company sits at the center of the biggest infrastructure buildout in the history of artificial intelligence, with a $750 billion spending commitment from OpenAI and a $638 billion backlog of unfulfilled contracts. Yet its stock is trading at roughly $110 — just 5% above a 52-week low — and has shed more than a third of its value since January. The tension between Oracle’s long-term promise and its near-term financial strain has rarely been sharper.

The immediate catalyst for the week came from a customer, not from the company itself. OpenAI announced Wednesday that it would raise its planned computing investments to roughly $750 billion by 2030, up from a previous target of $600 billion. Oracle is a direct beneficiary: it continues to lease significant chip capacity from its cloud infrastructure to OpenAI, and it is building “Project Camellia,” a $20 billion data center in Georgia. The message is unmistakable — OpenAI is scaling its own capacity but still depends on external partners like Oracle for the heavy lifting.

That demand is reflected in Oracle’s order book. The company’s remaining performance obligations — contracts signed but not yet delivered — stand at $638 billion, a 363% surge from a year ago. Management expects to convert roughly 12% of that backlog into revenue in the coming fiscal year, which would translate to about $77 billion. The bull case rests on the idea that Oracle has secured a decade of revenue visibility as a neutral infrastructure partner for the world’s largest cloud providers, including AWS, Google Cloud, and Microsoft Azure — former competitors that now serve as distribution channels for Oracle’s high-margin database business.

But the numbers on the other side of the ledger tell a different story. Oracle’s capital expenditures have climbed to $55.7 billion in the current fiscal year, and the company plans to invest $70 billion net in the next one. Much of that spending is tied to the “Stargate” project, a joint venture with OpenAI to build AI data centers. The result is a negative free cash flow of $23.7 billion. Total debt sits at roughly $156 billion.

The company’s plan to raise an additional $40 billion in the coming fiscal year — including a $20 billion equity program — is adding to investor anxiety. If Oracle issues new shares at current depressed prices, existing shareholders face meaningful dilution. The credit rating agency S&P has already downgraded Oracle to BBB-, just one notch above junk territory. Any cooling in AI demand or delays in data center deliveries could push financing costs higher and trigger further downgrades.

Even Oracle’s own security update this week carried a dual message. On Tuesday, the company released its largest-ever patch bundle: 1,449 fixes for 1,235 vulnerabilities across 32 product families. About 77% of the flaws came from Oracle’s own code, which the company attributed to new AI-driven detection systems. That same day, it launched “Base Database Cloud@Customer,” a system for mid-sized locations running on fifth-generation AMD Epyc processors that allows clients to operate the Oracle AI Database 26ai locally while maintaining cloud connectivity. The product is a reminder of Oracle’s technical depth — but it hasn’t moved the stock.

There was also good news from a subsidiary. Oracle Financial Services Software (OFSS), majority-owned by Oracle, reported first-quarter results for fiscal 2027 on Thursday. Net profit jumped 121% to 1,416 crore rupees, while revenue climbed 69% to 3,125 crore rupees, driven by a one-time licensing deal with a large international bank. The same day, CEO Makarand Padalkar stepped down, replaced by former CFO Avadhut Ketkar. The transition was orderly, but it adds another variable to a story already full of them.

The technical picture offers a glimmer of hope for the bulls. The 14-day relative strength index sits at 32.4, signaling an oversold condition. The average analyst price target is $218.39, nearly double the current level. But the stock is trading 31% below its 200-day moving average of roughly $160, and it is 26% below the 50-day average of about $150. The 52-week low of $105.10 was touched just a week ago, and a break below that level could trigger further algorithm-driven selling.

The next major test comes in September 2026, when Oracle reports first-quarter results for the new fiscal year. By then, investors will want to see whether the $638 billion backlog is actually converting toward the company’s annual revenue target of $90 billion. Until then, with annualized volatility at 46%, the stock is likely to remain a battleground between those who see a decade of locked-in growth and those who see a balance sheet stretched to the breaking point.